Your email has been successfully added to our mailing list.

×
-8.95175006714271E-05 0.000358070002685454 0.000626622504699608 0.0036702175275266 0.0020589025154418 0.00241697251812726 -0.00277504252081284 -0.0036702175275266
Stock impact report

Crispr Therapeutics: Now Is The Time To Buy [Seeking Alpha]

CRISPR Therapeutics AG - Common Shares (CRSP) 
Last crispr therapeutics ag - common shares earnings: 8/7 05:01 pm Check Earnings Report
US:NASDAQ Investor Relations: nasdaq.com/symbol/crsp/real-time
Company Research Source: Seeking Alpha
The company's pipeline of treatments for various diseases presents a significant opportunity for future growth and market expansion. CRISPR Therapeutics has managed financial risks through partnerships and has enough cash on hand to fund operations for at least 24 months. Buying companies with breakthrough science or technologies can be difficult as their stock is often priced highly with respect to its revenues, earnings, and cash flows. As much as I'd like to be on the ground floor, any time there's excitement about Recommended For You Recommended For You About CRSP Stock Show less Read more
Impact Snapshot
Event Time:
CRSP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for CRSP alerts
Opt-in for
CRSP alerts

from News Quantified
Opt-in for
CRSP alerts

from News Quantified